Atlas Trials

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Clinical trial NCT02463643 · COMPLETED

Trial details

NCT number
NCT02463643
Sponsor
Zeria Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophagitis, Reflux
Start date
2015-05-01
Primary completion
2016-10-01
Enrollment
503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.